Aegirbio AB
SEK0.97
1
+SEK0.01+0.73% Today
Statistics
Day High
1.01
Day Low
0.91
52W High
7.3
52W Low
0.52
Volume
155,431
Avg. Volume
154,823
Mkt Cap
43.99M
P/E Ratio
-
Dividend Yield
-
Dividend
-
People Also Follow
This list is based on the watchlists of people on Stock Events who follow AEGIR.ST. It's not an investment recommendation.
About
AegirBio AB (publ), a diagnostic company, develops and commercializes tests to follow the dosage of biological drugs. The company focuses on therapeutic drug monitoring of biologic therapies in the multiple sclerosis, cancer, and autoimmune diseases. It offers moNATor, a first dose-monitoring laboratory test to test multiple sclerosis for healthcare professionals and patients; and Viraspec, a COVID-19 saliva test kit. The company was incorporated in 2019 and is based in Lund, Sweden.
Show more...
CEO
Dr. Bradley Messmer Ph.D.
Employees
17
Country
Sweden
ISIN
SE0014401121
WKN
000A2P7ZC